argenx SE reported 1.04B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AstraZeneca USD 33.54B 4.41B Jun/2025
Galapagos EUR 402.95M 34.09M Jun/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
GRIFOLS EUR 1.99B 180.07M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Qiagen NV USD 1.13B 611.37M Jun/2025
UCB EUR 3.53B 731M Dec/2024